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1. INTRODUCTION {#fsn31194-sec-0001}
===============

*Bifidobacterium* is a genus of gram‐positive bacteria that colonize in the human gastrointestinal tract and provide health benefits. Several studies verified a wide range of positive effects for *Bifidobacterium*, including the protection against pathogenic bacteria, alleviation of allergic disease symptoms (Casaro et al., [2018](#fsn31194-bib-0005){ref-type="ref"}), immune regulation, reduction in intestinal inflammations, and the potential of bifidobacteria to prevent and/or treat colorectal cancer (Le Leu, Hu, Brown, Woodman, & Young, [2010](#fsn31194-bib-0014){ref-type="ref"}). Due to claimed health benefits, bifidobacteria has been incorporated into many functional foods (O\'Callaghan & van Sinderen, [2016](#fsn31194-bib-0024){ref-type="ref"}). Therefore, more health benefits are expected if the amount of bifidobacteria could be increased in the body.

Xylo‐oligosaccharides (XOSs) are hydrolysates of xylan and consist of a backbone of xylose, which are noncaloric and indigestible by humans. XOSs are believed to exert bifidogenic effects and are increasingly used as prebiotics. XOS may be beneficial in stimulating the intestinal *Bifidobacterium* without significant effect on *lactobacillus* (Li, Summanen, Komoriya, & Finegold, [2015](#fsn31194-bib-0017){ref-type="ref"}; Falck et al., [2013](#fsn31194-bib-0009){ref-type="ref"}). Also, it was found that XOS increases bifidobacteria, but not lactobacilli in human gut microbiota (Finegold et al., [2014](#fsn31194-bib-0010){ref-type="ref"}). Due to potential bifidobacteria proliferation effects, XOSs have attracted increasing interest.

Carbohydrate metabolism may vary among bifidobacterial strains considerably (Pokusaeva, Fitzgerald, & Sinderen, [2011](#fsn31194-bib-0025){ref-type="ref"}). *Bifidobacterium adolescentis* has the ability to utilize XOS efficiently (Amaretti et al., [2013](#fsn31194-bib-0001){ref-type="ref"}). Bifidobacteria lack a number of key enzymes involved in the Embden--Meyerhof--Parnas (EMP) pathway; therefore, bifidobacteria metabolize carbohydrates through a metabolic pathway named the "bifid shunt," which is centered on the key enzyme fructose‐6‐phosphoketolase (De Vries & Stouthamer, [1967](#fsn31194-bib-0007){ref-type="ref"}). In a previous study, we have found that the growth rate of *B. adolescentis* was higher in the presence of XOS than xylose (unpublished). However, the underlying molecular regulation mechanisms of XOS metabolism are not fully understood. In XOS utilization process, xylose is not neatly consumed and remaining unfermented (Amaretti et al., [2013](#fsn31194-bib-0001){ref-type="ref"}). Although it has been established that XOSs confer positive benefits to bifidobacteria, there is a lack of knowledge regarding the molecular mechanisms that explain the metabolic pathway of XOS in *B. adolescentis*. Meanwhile, a recent study performed on the genome sequences from 47 *Bifidobacterium* (sub) species found that 5.5% of the core bifidobacterial genomic coding sequences are associated with carbohydrate metabolism (Pokusaeva et al., [2011](#fsn31194-bib-0025){ref-type="ref"}). Therefore, an in‐depth study on these functional genes has significance for understanding mechanisms of probiotic effects of *Bifidobacterium*. In this work, a combination of transcriptome and metabolome analyses was applied to elucidate the molecular mechanism for utilizing and metabolism of xylose and XOS in *B. adolescentis* 15703. Understanding of basic mechanisms may help in finding of novel ways to optimize the use of prebiotics and probiotics in the food industry.

2. MATERIALS AND METHODS {#fsn31194-sec-0002}
========================

2.1. Materials {#fsn31194-sec-0003}
--------------

*Bifidobacterium adolescentis* ATCC 15703 was purchased from China General Microbiological Culture Collection Center. XOS extracted from corncob, 95% purity, DP of 2--7 and containing 22.76% xylobiose, 31.45% xylotriose, 20.37% xylotetraose, 10.89% xylopentaose, 4.68% xylohexaose, and 6.37% wood seven sugar was obtained from LongLive Biotechnology. All other chemicals were of analytical grade.

2.2. Bacterial cultivation and carbohydrates fermentation {#fsn31194-sec-0004}
---------------------------------------------------------

*Bifidobacterium adolescentis* 15703 was resuscitated and precultivated twice using MRS broth. Cells were harvested and suspended as 2% inoculate into MRS medium containing xylose or XOS as well as a control medium without carbohydrate and incubated at 37°C under anaerobic conditions. Aliquots of cultures were drawn at regular intervals and cell growth was determined by measuring the optical density at 600 nm (Lei et al., [2018](#fsn31194-bib-0015){ref-type="ref"}).

2.3. RNA extraction {#fsn31194-sec-0005}
-------------------

Cells were harvested from triplicate cultures at the estimated early midexponential growth phase by centrifugation at 4,000 *g* for 10 min at 4°C for RNA isolation and purification. The samples were used for RNA extraction following the manufacturer\'s recommendations of QIAGEN 74524 kit. RNA concentration was determined with a Qubit RNA Assay Kit in a Qubit 2.0 fluorometer (Life Technologies). RNA purity and integrity were assessed by a Nanodrop spectrophotometer (IMPLEN).

2.4. Library construction and sequencing {#fsn31194-sec-0006}
----------------------------------------

After total RNA extraction, prokaryotic mRNA was enriched by removing rRNA using Ribo‐Zero™ Magnetic Kit (Epicentre). Then the short fragments were obtained from the enriched mRNA by fragmentation buffer and were reverse transcripted into cDNA. Under the action of DNA polymerase I, RNase H and dNTP, second‐strand cDNA was synthesized. Then, the cDNA fragments were purified, end repaired, poly (A) added, and ligated to Illumina sequencing adapters (Bellieny‐Rabelo et al., [2019](#fsn31194-bib-0002){ref-type="ref"}). The ligation products size were chosen, amplified, and sequenced using Illumina HiSeq™ 2500.

2.5. Transcriptomic analysis {#fsn31194-sec-0007}
----------------------------

Raw reads were filtered to remove some adapters and low‐quality reads, and the remaining reads were mapped to a reference genome by TopHat2 (Kim et al., [2013](#fsn31194-bib-0013){ref-type="ref"}). The reconstruction of transcripts was carried out with software Cufflinks (Trapnell et al., [2012](#fsn31194-bib-0028){ref-type="ref"}), then the transcripts were merged from multiple groups into a finally comprehensive set of transcripts for further downstream differential expression analysis. Gene abundances were quantified by software RSEM (Li & Dewey, [2011](#fsn31194-bib-0016){ref-type="ref"}). The gene expression level was normalized with FPKM method, and the edgeR package was used to identify DEGs across groups. In comparison as significant DEGs, FDR \<0.01 and fold change (FC) ≥2 were used as screening criteria. We conducted gene expression differences between xylose and XOS treatments using the DEseq package. DEGs were then subjected to enrichment analysis of COG functions and KEGG pathways.

2.6. Confirmation of transcriptomic results by quantitative real‐time PCR {#fsn31194-sec-0008}
-------------------------------------------------------------------------

Total RNA was isolated as described above. Using a Revert Aid Premium Reverse Transcriptase, the cDNA synthesis was performed. qRT‐PCR primers are listed in Table [1](#fsn31194-tbl-0001){ref-type="table"} and each reaction (20 μl mixture) contained 2 μl cDNA, 10 μl 2 × sybrGreen qPCR Master Mix, 0.4 μl the forward and reverse primers and 7.6 μl water. All qRT‐PCR were performed in ABI Stepone plus and performed in two steps: Firstly, predenaturation for 3 min and 45 cycles of denaturation for 3 s at 95°C, then annealing/extension for 30 s at 60°C. Gene expression was normalized by the $2^{- \Delta\Delta C_{t}}$ method, and the 16S rRNA gene was used as the normalized standard.

###### 

Selected genes and primers for qRT‐PCR

  Target genes ID            Discription                                        Primer sequence           Tm     Length (bp)
  -------------------------- -------------------------------------------------- ------------------------- ------ -------------
  BAD_RS02255                Sugar ABC transporter substrate‐binding protein    F:AGGAAGGTGCTTTGATGGG     57.2   116
  R:GGCGTATTTCTCCTGATTTGA    57.2                                                                                
  BAD_RS02260                Sugar ABC transporter permease                     F:CTTCGTGCCGTATGTCGTTT    58.7   246
  R:TGGCTGCTTCATACAGTTCC     57.9                                                                                
  BAD_RS00875                Phosphoenolpyruvate‐protein phosphotransferase     F:TGTTCCGTACCGAATTCCTGT   59.5   117
  R:TGCGGATCACGACCTTCTT      58.5                                                                                
  BAD_RS01940                PTS beta‐glucoside transporter subunit EIIBCA      F:ACGCTCGGCTACGACTTCAT    59.9   200
  R:AGCTTGTACCGCAGGTGGAT     58.5                                                                                
  BAD_RS06365                Beta‐glucosidase                                   F:CTTCTACATCACCGCCTACCA   57.8   167
  R:TATCGAGGACCACGTTCTTAAA   57.2                                                                                
  BAD_RS02270                Beta‐xylosidase                                    F:CCAGCCAGCTTGATATGAGAG   57.6   154
  R:TCGGCGGTGACCAAATAA       57.8                                                                                
  BAD_RS03990                Glutamate synthase \[NADPH\] large subunit         F:TCGTGCATTCCCGCTTC       58.0   103
  R:TTGCCTTGGATGGTGTTGA      57.4                                                                                
  BAD_RS04070                Dihydroorotate oxidase                             F:GAACAGCACGAATGGAAGCA    59.3   188
  R:GCAGTACGGATGCCAGGATT     59.9                                                                                
  BAD_RS07900                dTDP‐glucose 4,6‐dehydratase                       F:GTTCACGGAGCATACCCCATA   59.9   147
  R:TGCTGGAAGGGACCGTAGTT     59.5                                                                                
  BAD_RS08125                Molecular chaperone DnaK                           F:ACCGACTGGACCGTTGAGAT    59.0   156
  R:CTGGGCGTCGTTGAAGTATG     59.0                                                                                
  BAD_RS07405                Multiple sugar‐binding transport system permease   F:CAACGCCTTCAAGAACACC     56.1   200
  R:GACCCACCTGTGCCTCCAT      59.9                                                                                
  BAD_RS01610                Xylanase                                           F:ATGACGGAAAGCCGCATGT     57.6   163
  R:CGGTCGTGGGTCAGGAAGA      59.6                                                                                
  BAD_RS03215                ABC transporter permease                           F:CTCATCTCGCTCGTCTCCG     58.8   200
  R:GGTACTTTGACCGCTCTGC      55.4                                                                                
  BAD_RS06375                MFS transporter                                    F:GAACATGATGATCGCACCG     57.3   190
  R:GGAAAGACCCATAGCCACA      55.4                                                                                
  BAD_RS02300                Membrane‐associated protein                        F:CTGCTCGCTCGTCCTCGTC     60.7   170
  R:TCTCCACTTTGCCCGTTCC      61.2                                                                                
  BAD_RS03325                ABC transporter ATP‐binding protein                F:GTCCTTCGCCATCGAGCCT     63.4   158
  R:CACTGCTGCGGGGTGAAAT      63.9                                                                                
                             16S rRNA                                           F:GAGCGAACAGGATTAGATAC    57.6   144
  R:TCTTTGAGTTTTAGCCTTGC     58.0                                                                                
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2.7. Metabolites extraction {#fsn31194-sec-0009}
---------------------------

The sample of 100 μl was accurately removed and placed in EP tube, and 300 μl methanol was added to start extraction, add 20 μl internal standard substances and followed by vortex for 30 s. Then, the mixture tube was immersed into the ultrasonic bath with ice water and ultrasonically incubated in ice water for 10.0 min and incubated for 1 hr at −20°C to precipitate proteins. Then, the mixture was centrifuged at 11,390 *g* for 15 min at 4°C. About 200 μl of supernatant sample was transferred to a fresh 2 ml LC/MS glass vial, 20 μl from supernatant of each sample was marked as QC samples, and another supernatant was used for the UHPLC‐QTOF‐MS analysis. All experiments were carried out in triplicate.

2.8. LC‐MS/MS analysis {#fsn31194-sec-0010}
----------------------

The UHPLC system (1290, Agilent Technologies) with a UPLC BEH Amide column (1.7 μm 2.1 × 100 mm, Waters) coupled with Triple TOF 5600 (Q‐TOF, AB Sciex) was used for LC‐MS/MS analyses. 25 mM NH~4~OAc and 25 mM NH~4~OH in water (pH = 9.75) (A) and acetonitrile (B) were used as the mobile phase. The elution gradient was as follows: 0 min, 95% B; 7 min, 65% B; 9 min, 40% B; 9.1 min, 95% B; and 12 min, 95% B. The flow rate of the mobile phase was 0.5 ml/min. The injection volume of analytical solution was 3 μl. The Triple‐TOF‐MS was used for its ability to acquire MS/MS spectra on an information‐dependent basis (IDA) during an LC/MS experiment. In this mode, the full scan survey MS data as it collects and triggers the acquisition of MS/MS spectra depending on preselected criteria were surveyed by the acquisition software (Analyst TF 1.7, AB Sciex; Fraga, Clowers, Moore, & Zink, [2010](#fsn31194-bib-0011){ref-type="ref"}). In each cycle, 12 precursor ions with intensity greater than 100 were chosen for fragmentation at collision energy (CE) of 30 V (15 MS/MS events with product ion accumulation time of 50 msec each). ESI source conditions were set as following: ion source gas 1 as 60 Psi, ion source gas 2 as 60 Psi, Curtain gas as 35 Psi, source temperature 650°C, ion spray voltage floating (ISVF) 5,000 or −4,000 V in positive or negative modes, respectively.

2.9. Data processing and analysis {#fsn31194-sec-0011}
---------------------------------

The mzXML format were obtained by using ProteoWizard to convert MS raw data files, and processed by R package XCMS (version 3.2). The processed results generated a data matrix consisted of retention time (RT), massto‐charge ratio (*m*/*z*) values, and peak intensity. R package CAMERA was used for peak annotation after XCMS data processing (Kim et al., [2013](#fsn31194-bib-0013){ref-type="ref"}). The metabolites were identified by In‐house MS~2~ database.

3. RESULTS {#fsn31194-sec-0012}
==========

3.1. Growth characteristics of *B. adolescentis* 15703 {#fsn31194-sec-0013}
------------------------------------------------------

The growth characteristics of *B. adolescentis* 15703 on xylose and XOS are presented in Figure [1](#fsn31194-fig-0001){ref-type="fig"}. *Bifidobacterium adolescentis* grew better on xylose and XOS as carbon sources compared with CK (control group) without carbon source. Also, a rapid growth rate was observed when XOS was used compared with xylose. The growth yield (stable phase) on XOS was about 1.5‐fold greater than that on xylose, indicating that XOS was more preferred by *B. adolescentis*.

![Growth of *Bifidobacterium adolescentis* 15703 on Xylo‐oligosaccharide (XOS), xylose, and control medium (no carbohydrate)](FSN3-7-3480-g001){#fsn31194-fig-0001}

3.2. RNA‐seq analysis and differential gene expression {#fsn31194-sec-0014}
------------------------------------------------------

From the RNA‐seq analysis data, it can be seen that over 99% of the reads were aligned to encoding regions of the *B. adolescentis*. Genes were assigned to 25 functional groups, which were annotated in COG database (Figure [2](#fsn31194-fig-0002){ref-type="fig"}). Among these classifications, the largest group was amino acid transport and metabolism (191, 13.45%), followed by carbohydrate transport and metabolism (160, 11.27%) and general function prediction (151, 10.63%).

![COG function classification of genes in *Bifidobacterium adolescentis* 15703. The categories of the COG are shown on the horizontal axis, and gene numbers are plotted on the vertical axis](FSN3-7-3480-g002){#fsn31194-fig-0002}

A total number of 302 DEGs were identified for *B. adolescentis* grown on xylose and XOS, including 158 upregulated genes and 144 downregulated genes (Figure [3](#fsn31194-fig-0003){ref-type="fig"}). The top 10 upregulated genes and 10 downregulated genes of xylose and XOS treatments are presented in Table [2](#fsn31194-tbl-0002){ref-type="table"}. Four genes of the top 10 upregulated genes encode ABC and MFS transporters. Among the remaining genes, two genes encode hsp20/alpha crystallin family protein and ATP‐dependent chaperone ClpB, two genes encode RNA polymerase sigma factor and death‐on‐curing protein, other two genes encode enzyme proteins belonging to multiple sugar‐binding transport system permease and shikimate kinase. Five genes of the top 10 downregulated genes encode structure protein, including penicillin‐binding protein, von willebrand factor type A domain protein, fhiA protein, arginine repressor DUF4956, domain‐containing protein, three genes are associated with membrane transport, including peptide ABC transporter ATP‐binding protein, ABC transporter permease, and membrane spanning polysaccharide biosynthesis protein, while two genes encode O‐antigen polymerase and hypothetical protein.

![Change level of global DEGs between XOS and xylose treatment. Red dot: upregulated; green dot: downregulated; black dot: not DEGs](FSN3-7-3480-g003){#fsn31194-fig-0003}

###### 

Top 10 significantly upregulated and downregulated genes during growth of *Bifidobacterium adolescentis* 15703 on XOS compared with xylose assessed by RNAseq

  Gene no.[a](#fsn31194-note-0001){ref-type="fn"}   Log~2~ (Fc)[b](#fsn31194-note-0002){ref-type="fn"}   Annotation[c](#fsn31194-note-0003){ref-type="fn"}       Linear FMPK value[d](#fsn31194-note-0004){ref-type="fn"}   
  ------------------------------------------------- ---------------------------------------------------- ------------------------------------------------------- ---------------------------------------------------------- ----------
  BAD_RS07405                                       3.63↑                                                Multiple sugar‐binding transport system permease        160.73                                                     12.98
  BAD_RS05940                                       3.51↑                                                MFS transporter                                         6.71                                                       0.59
  BAD_RS01050                                       3.47↑                                                Shikimate kinase                                        173.6                                                      15.68
  BAD_RS07410                                       3.27↑                                                ABC transporter permease                                159.79                                                     16.53
  BAD_RS07415                                       3.23↑                                                ABC transporter, solute‐binding protein                 486.74                                                     51.88
  BAD_RS08735                                       3.18↑                                                RNA polymerase sigma factor                             18.24                                                      2.01
  BAD_RS00260                                       3.01↑                                                hsp20/alpha crystallin family protein                   13,180.79                                                  1,634.87
  BAD_RS02255                                       2.85↑                                                Sugar ABC transporter substrate‐binding protein         7,109.23                                                   989.28
  BAD_RS05015                                       2.83↑                                                Death‐on‐curing protein                                 89.91                                                      12.64
  BAD_RS07715                                       2.83↑                                                ATP‐dependent chaperone ClpB                            3,432.39                                                   484.32
  BAD_RS00210                                       2.08↓                                                Penicillin‐binding protein                              120.14                                                     505.44
  BAD_RS07300                                       2.14↓                                                O‐antigen polymerase                                    28.92                                                      127.77
  BAD_RS02985                                       2.20↓                                                Hypothetical protein                                    32.4                                                       148.91
  BAD_RS02975                                       2.22↓                                                von Willebrand factor type A domain protein             44.03                                                      204.58
  BAD_RS08925                                       2.25↓                                                fhiA protein                                            22.97                                                      109.11
  BAD_RS03210                                       2.35↓                                                Peptide ABC transporter ATP‐binding protein             97.09                                                      496.58
  BAD_RS07325                                       2.41↓                                                Membrane spanning polysaccharide biosynthesis protein   22.11                                                      117.21
  BAD_RS04925                                       2.53↓                                                Arginine repressor                                      43.27                                                      250.28
  BAD_RS02140                                       2.69↓                                                DUF4956 domain‐containing protein                       3.07                                                       19.86
  BAD_RS03215                                       2.99↓                                                ABC transporter permease                                60.43                                                      480.91

Gene number referenced as *B. adolescentis* 15703 being alphabet and a five‐digit number.

Significance of fold change data is judged by having a *p* value of no more than .01.

Gene annotations were blasted against Swiss prot.

FPKM (fragments per kilobase of exon per million fragments mapped) values for cultures on media with Xylose or XOS.
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3.3. KEGG pathway mapping of DEGs {#fsn31194-sec-0015}
---------------------------------

The DEGs involved in biological functions were further analyzed by KEGG pathways, and 20 pathways were predicted (Figure [4](#fsn31194-fig-0004){ref-type="fig"}). ABC transporters, galactose metabolism, peptidoglycan biosynthesis pyrimidine metabolism, starch, and sucrose metabolism are the highly represented categories.

![KEGG pathway enrichment analysis of DEGs (XOS vs. xylose). The vertical axis indicates the name of KEGG pathway, and the horizontal axis indicates the Rich factor. The dot size indicates the number of differentially expressed genes in the pathway, and the color of the dots corresponds to different *Q* values](FSN3-7-3480-g004){#fsn31194-fig-0004}

The DEGs involved in the ABC transporters are shown in Table [3](#fsn31194-tbl-0003){ref-type="table"}. In the ABC transporter pathway (ko02010), 27 genes were significantly upregulated. Genes 07405, 07410, 02260, 08210, 08205, 00815, 00810, 08280, 03705, 08275, 06685, 08210 encoded ABC transporter permease, Genes 07415, 02255, 01495, 00390, 00805, 08285, 00990, 06680 encoded ABC transporter substrate‐binding protein, Gene 02265, 04090, 00495, 03325, 08375 encoded ABC transporter ATP‐binding protein, 07050 and 00340 encoded ABC transporter, while nine genes (02355, 02470 and 03935), which are ABC transporter‐related genes, significantly downregulated after XOS treatment.

###### 

DEGs involved in related ABC transporter during growth of *Bifidobacterium adolescentis* 15703 on XOS compared with xylose assessed by RNAseq

  Gene no.      Log~2~ (Fc)   Symbol    Annotation                                                                 Linear FMPK value   
  ------------- ------------- --------- -------------------------------------------------------------------------- ------------------- -----------
  BAD_RS07405   3.02↑         amyC      Multiple sugar‐binding transport system permease                           105.08              12.98
  BAD_RS07410   3.27↑         amyD      ABC transporter permease                                                   159.79              15.53
  BAD_RS07415   2.80↑         mdxE      ABC transporter, solute‐binding protein                                    360.4               51.88
  BAD_RS02255   3.00↑         yurO      Sugar ABC transporter substrate‐binding protein                            7,940.17            989.28
  BAD_RS01495   2.69↑         TP_0034   ABC transporter substrate‐binding protein                                  2,060.19            319.83
  BAD_RS00390   2.33↑         BR1785    Branched‐chain amino acid ABC transporter substrate‐binding protein        30.52               6.05
  BAD_RS02265   2.38↑         yurM      Thiamine ABC transporter ATP‐binding protein                               2,679.25            514.59
  BAD_RS02260   2.34↑         malF      Sugar ABC transporter permease                                             2,356.22            466
  BAD_RS00385   2.28↑         livF      ABC‐type branched‐chain amino acid transport systems ATPase component      25.2                5.2
  BAD_RS08210   1.99↑         amyD      Permease of ABC transporter possibly for oligosaccharides                  3,704.78            933.34
  BAD_RS00805   1.95↑         yurO      Solute‐binding protein of ABC transporter system                           2,384.03            618.73
  BAD_RS08205   1.88↑         amyC      Sugar ABC transporter permease                                             2,223.03            603.5
  BAD_RS00495   1.76↑         MT1311    Multidrug ABC transporter ATP‐binding protein                              276.15              81.69
  BAD_RS07050   1.58↑         lipO      ABC transporter                                                            10,020.43           3,361.71
  BAD_RS08285   1.52↑         ugpB      ABC transporter, solute‐binding protein                                    1,971.94            686.94
  BAD_RS00815   1.48↑         araQ      Sugar ABC transporter permease                                             911.12              326.41
  BAD_RS08280   1.46↑         msmF      Sugar ABC transporter permease                                             1,353.65            491.14
  BAD_RS00810   1.45↑         yurN      Sugar ABC transporter permease                                             762.04              278.86
  BAD_RS03705   1.35↑         ---       ABC transporter permease                                                   91.4                35.95
  BAD_RS00990   1.33↑         ---       ABC transporter substrate‐binding protein                                  34.99               13.91
  BAD_RS03325   1.29↑         MJ1508    ABC transporter ATP‐binding protein                                        209.24              85.46
  BAD_RS08275   1.27↑         amyC      ABC transporter permease                                                   1,000.47            413.73
  BAD_RS04090   1.14↑         TM_0352   Macrolide ABC transporter ATP‐binding protein                              33.93               15.42
  BAD_RS00340   1.05↑         Pip       ABC transporter                                                            228.58              109.76
  BAD_RS06680   1.27↑         yxeM      Amino acid ABC transporter substrate‐binding protein                       552.97              228.62
  BAD_RS06685   1.05↑         tcyL      ABC transporter permease                                                   409.27              196.97
  BAD_RS00370   1.04↑         livH      Branched‐chain amino acid ABC‐type transport system permease components    17.92               8.75
  BAD_RS08375   1.02↑         msmX      ABC transporter ATP‐binding protein                                        38,386.82           18,870.88
  BAD_RS03070   1.01↓         artQ      Glutamine ABC transporter permease                                         89.94               181.07
  BAD_RS02355   1.03↓         braC      Solute‐binding protein of ABC transporter for branched‐chain amino acids   83.57               171.31
  BAD_RS02470   1.05↓         ftsX      ABC transporter permease                                                   240.08              497.88
  BAD_RS03935   1.07↓         rbsA1     ABC transporter ATP‐binding protein                                        10.55               22.14
  BAD_RS04785   1.22↓         yclH      ATP‐binding protein of ABC transporter similar to Vex2                     40.66               94.55
  BAD_RS05605   1.28↓         ---       Sugar ABC transporter substrate‐binding protein                            101.96              247.02
  BAD_RS03930   1.33↓         ---       Cobalt ABC transporter permease                                            12.88               32.39
  BAD_RS03210   2.35↓         lolD      Peptide ABC transporter ATP‐binding protein                                97.09               496.58
  BAD_RS03215   2.76↓         macB      ABC transporter permease                                                   71.17               480.91
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The DEGs involved in carbohydrate metabolism are shown in Table [4](#fsn31194-tbl-0004){ref-type="table"}. Compared with xylose treatment, five genes (08325, 07400, 07395, 06400, 08455) encoded beta‐galactosidase and two genes (08195, 08270) encoded alpha‐amylase related to galactose metabolism pathway (ko00052) significantly upregulated after XOS treatment. Also, three genes (02270, 08480, 02400) expressed key enzymes (beta‐xylosidase, beta‐glucosidase) involved in starch and sucrose metabolism (ko00500) significantly upregulated after XOS treatment. Gene 05480 coded mannan endo‐1,4‐beta‐mannosidase involved in fructose and mannose metabolism (ko00051). 01050 coded shikimate kinase, 01040 coded 6‐phosphogluconate dehydrogenase, 02150 coded lactaldehyde reductase, 07445 coded L‐ribulose‐5‐phosphate 4‐epimerase, 01580 coded UDP‐N‐acetylenolpyruvoylglucosamine reductase, which involved in biosynthesis of antibiotics (ko01130), microbial metabolism in diverse environments (ko01120) carbon metabolism (ko01200), pentose phosphate pathway (ko00030), glyoxylate and dicarboxylate metabolism (ko00630), propanoate metabolism (ko00640), and pentose and glucuronate interconversions (ko00040).

###### 

DEGs involved in related carbohydrate metabolism in KEGG pathway during growth of *Bifidobacterium adolescentis* 15703 on XOS compared with xylose assessed by RNAseq

  Gene no.      Log~2~ (Fc)   Symbol     Annotation                                                 Linear FMPK value   KEGG pathway   
  ------------- ------------- ---------- ---------------------------------------------------------- ------------------- -------------- -------------------------------------------------------------------------
  BAD_RS01050   3.47↑         Idnk       Shikimate kinase                                           173.6               15.68          ko01100
  BAD_RS07400   2.44↑         BGAL16     Beta‐galactosidase                                         70.88               13.06          ko01100/ko00052/ko00600/ko00511
  BAD_RS01040   2.42↑         gnd        6‐phosphogluconate dehydrogenase                           240.52              45.07          ko01100/ko01110/ko01130/ko01120//ko01200/ko00030/ko00480
  BAD_RS08195   2.20↑         malL       Alpha‐amylase                                              3,359.55            733.05         ko01100/ko00500/ko00052
  BAD_RS02270   2.08↑         xynB       Beta‐xylosidase                                            1,066.15            251.3          ko01100/ko00500/ko00052
  BAD_RS08325   1.97↑         LacZ       Beta‐galactosidase                                         98.72               25.2           ko01100/ko00052/ko00600/ko00511
  BAD_RS02150   1.68↑         fucO       Lactaldehyde reductase                                     5,736.74            1,795.21       ko01120/ko00630/ko00640
  BAD_RS08455   1.38↑         lacZ       Beta‐galactosidase                                         329.16              126.46         ko01100/ko00052/ko00600/ko00511
  BAD_RS08270   1.34↑         malL       Alpha‐amylase                                              1,248.09            493.04         ko01100/ko00500/ko00052
  BAD_RS07445   1.26↑         ulaF       L‐ribulose‐5‐phosphate 4‐epimerase                         549.87              229.09         ko01100/ko00040
  BAD_RS06365   1.23↑         exgA       Beta‐glucosidase                                           1,112.17            475.02         ko00500
  BAD_RS06400   1.19↑         bgaB       Beta‐galactosidase                                         45.11               19.79          ko00052
  BAD_RS01695   1.18↑         ---        Sulfurtransferase                                          20.92               9.24           ko01100/ko00040
  BAD_RS02400   1.16↑         malL       Alpha‐glucosidase                                          76.25               34.21          ko01100/ko00500/ko00052
  BAD_RS06090   1.14↑         cscA       Beta‐(1‐2)‐fructofuranosidase                              47.64               21.63          ko01100/ko00500/ko00052
  BAD_RS05480   1.11↑         BAD_1030   Mannan endo‐1,4‐beta‐mannosidase                           29.85               13.79          ko00051
  BAD_RS01580   1.08↑         murB       UDP‐N‐acetylenolpyruvoylglucosamine reductase              198.47              93.71          ko01100/ko00520/ko00550
  BAD_RS08480   1.06↑         bglB       Beta‐glucosidase                                           137.7               66.25          ko01100/ko01110/ko00500/ko00460
  BAD_RS07395   1.05↑         bgaB       Beta‐galactosidase I                                       175.7               84.64          ko00052
  BAD_RS05595   1.05↓         acn        Aconitate hydratase                                        137.1               283.08         ko01100/ko01110/ko01130/ko01230/ko01120/ko01200/ko01210/ko00630/ko00020
  BAD_RS07575   1.25↓         glgE       Alpha‐1,4‐glucan‐maltose‐1‐phosphate maltosyltransferase   461.18              1,093.58       ko01100/ko00500
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3.4. Validation of transcript abundance using qRT‐PCR {#fsn31194-sec-0016}
-----------------------------------------------------

To verify the RNA‐Seq results, the mRNA expression of 16 selected candidate genes (eight upregulated and eight downregulated) was measured by qRT‐PCR. The expression levels of 16 DEGs with qRT‐PCR were compared with those of DEGs with RNA‐Seq by the linear fitting. A significant correlation (*R* ^2^ = 0.96345) was found between the RNA‐Seq and qRT‐PCR (Figure [5](#fsn31194-fig-0005){ref-type="fig"}). The qRT‐PCR results are consistent with their transcript abundance in RNA‐seq, which verified the accuracy of the DEGs from RNA‐seq analyses.

![Quantitative real‐time PCR (qRT‐PCR) validations of DEGs against RNA‐seq](FSN3-7-3480-g005){#fsn31194-fig-0005}

3.5. Metabolite profile {#fsn31194-sec-0017}
-----------------------

The metabolites profiling of *B. adolescentis* 15703 was performed using LC‐MS. The primary metabolites are amino acids, organic acids, fatty acid, polyhydroxy acids, sugars, phosphates, polyols, and *N*‐compounds. A total number of 157 different metabolites (MS~2~) were identified (*p* \< .05, log~2~FC \>1) for xylose and XOS treatments, including 79 upregulated metabolites and 78 downregulated metabolites. The top 10 upregulated and 10 downregulated metabolites for xylose and XOS treatments are presented in Table [5](#fsn31194-tbl-0005){ref-type="table"}. Six metabolites of the top 10 upregulated metabolites are acids, including linolenic acid, epoxy stearic acid, myristic acid, uric acid, palmitoleic acid, and oleic acid. The remaining metabolites are D‐sorbitol 6‐phosphate, 3‐prenyl‐4‐Hydroxyacetophenone, L‐threonine, and L‐phenylalanyl‐L‐proline. Three metabolites of the top 10 downregulated metabolites are 3‐Hydroxymandelic acid, 3‐Dehydroshikimic acid, vanillylmandelic acid, and other remaining metabolites are flutamide, dihydroxyfumarate, hydroxyhydroquinone, quinone, 3′‐O‐Methylinosine, N‐acetyl‐L‐alanine, and norepinephrine.

###### 

Top 10 significantly upregulated and downregulated metabolites during growth of *Bifidobacterium adolescentis* 15703 on XOS compared with xylose assessed by metabolome

  Meta ID     log~2~FC   MS~2~ name                           mzmed     rtmed
  ----------- ---------- ------------------------------------ --------- ---------
  meta_736    9.127↑     All cis‐(6, 9, 12)‐Linolenic acid    277.222   45.101
  meta_761    5.107↑     D‐Sorbitol 6‐phosphate               283.128   44.744
  meta_428    3.978↑     3‐Prenyl‐4‐Hydroxyacetophenone       220.130   250.897
  meta_827    3.251↑     Nname, cis‐9, 10‐Epoxystearic acid   297.248   62.159
  meta_468    3.091↑     Myristic acid                        227.205   45.097
  meta_458    2.915↑     Uric acid                            227.036   88.723
  meta_58     2.848↑     L‐Threonine                          118.053   239.084
  meta_607    2.675↑     cis‐9‐Palmitoleic acid               253.221   44.427
  meta_741    2.566↑     L‐phenylalanyl‐L‐proline             278.144   114.569
  meta_753    2.533↑     Oleic acid                           281.253   43.288
  meta_721    3.087↓     Flutamide                            275.064   118.82
  meta_459    3.105↓     3‐Hydroxymandelic acid               227.061   47.247
  meta_192    3.107↓     Dihydroxyfumarate                    169.043   48.585
  meta_65     3.131↓     Hydroxyhydroquinone                  125.027   206.664
  meta_182    3.220↓     Quinone                              167.039   48.545
  meta_750    3.387↓     3′‐O‐Methylinosine                   281.088   26.536
  meta_1000   4.285↓     3‐Dehydroshikimic acid               343.068   166.570
  meta_622    4.393↓     Vanillylmandelic acid                257.071   192.365
  meta_289    4.855↓     N‐Acetyl‐L‐alanine                   190.075   104.461
  meta_473    6.446↓     Norepinephrine                       228.092   67.598
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3.6. KEGG pathway mapping of metabolites {#fsn31194-sec-0018}
----------------------------------------

A total number of 50 enriched KEGG pathways were predicted, which were associated with different metabolites (Figure [6](#fsn31194-fig-0006){ref-type="fig"}). The 50 pathways were classified as environmental information processing, genetic information processing, and metabolism. The environmental information processing included ABC transporters and phosphotransferase system. In metabolism processing, microbial metabolism in diverse environments and biosynthesis of unsaturated fatty acids are the most highly represented (Figure [6](#fsn31194-fig-0006){ref-type="fig"}).

![The annotated and classified results of the differential metabolite in KEGG pathway](FSN3-7-3480-g006){#fsn31194-fig-0006}

Different metabolites involved in carbohydrate transport and metabolism are shown in Table [6](#fsn31194-tbl-0006){ref-type="table"}. Compared with xylose treatment, 10 metabolites (58, 911, 166, 1695, 82, 651, 15, 81, 348, 376), which are L‐threonine, cellobiose, D‐Mannose, maltotriose, L‐isoleucine, D‐biotin, glycerol, L‐leucine, N‐acetyl‐D‐glucosamine, D‐ribose are significantly different in the ABC transporters pathway (ko02010) for XOS treatment. Also, five metabolites, including D‐sorbitol 6‐phosphate, cellobiose, D‐mannose, L‐ascorbic acid, and N‐acetyl‐D‐glucosamine are significantly different in the phosphotransferase system (PTS; ko02060) for XOS treatment compared with xylose treatment. Isocitrate, citrate, and pyruvate are significantly different in Citrate cycle (TCA; ko00020). Sedoheptulose, isocitrate, tetrahydrofolate are significantly different in carbon fixation pathways in prokaryotes (ko00720). The remaining metabolites, which are galactinol, L‐ribulose, D‐glucose 6‐phosphate, 2‐keto‐D‐gluconic acid, and L‐threonine involved in galactose metabolism (ko00052), starch and sucrose metabolism (ko00500), pentose phosphate pathway (ko00030), biosynthesis of amino acids (ko01230), biosynthesis of secondary metabolites (ko01110), and so on.

###### 

Metabolites involved in related carbohydrate transport and metabolism in KEGG pathway during growth of *Bifidobacterium adolescentis* 15703 on XOS compared with xylose assessed by metabolome

  ID          MS~2~ name               mzmed     rtmed     log~2~Fc   KEGG_pathway_annotation
  ----------- ------------------------ --------- --------- ---------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  meta_761    D‐Sorbitol 6‐phosphate   283.128   44.744    5.11↑      ko02060/ko00051
  meta_58     L‐Threonine              118.053   239.084   2.85↑      ko00260/ko01130/ko01230/ko01110/ko02010/ko00860/ko00290/ko00970/ko01100/ko01120/ko00261
  meta_85     D‐Xylulose               131.038   357.043   2.45↑      ko00040/ko01100
  meta_2004   Galactinol               683.235   370.331   2.26↑      ko00052
  meta_991    Cellobiose               341.113   281.354   2.14↑      ko02010/ko00500/ko02060/ko01100
  meta_227    2‐keto‐D‐Gluconic acid   175.028   242.935   2.08↑      ko00030/ko01100/ko01120
  meta_135    Ribitol                  151.064   232.243   1.91↑      ko00740/ko00040/ko01100
  meta_166    D‐Mannose                161.048   418.573   1.41↑      ko00520/ko02060/ko02010/ko01100/ko00052/ko00051
  meta_211    Isocitrate               173.012   478.821   1.41↑      ko01210/ko00720/ko01200/ko01100/ko01120/ko00020/ko00630/ko01230/ko01130/ko01110
  meta_2096   Stachyose                725.246   464.357   1.36↑      ko00052
  meta_1317   Tetrahydrofolate         444.157   237.902   1.35↑      ko00720/ko01100/ko01200/ko01120/ko00970/ko00670/ko00790/ko00680/ko00260/
  meta_1695   Maltotriose              563.190   430.279   1.29↑      ko02010
  meta_295    Sedoheptulose            191.060   73.835    1.26↑      ko00710
  meta_82     L‐Isoleucine             130.090   221.442   1.15↑      ko01110/ko00460/ko01130/ko01230/ko00280/ko02010/ko01100/ko00290/ko00970/ko01210
  meta_651    D‐Biotin                 260.109   104.804   1.13↑      ko02010/ko01100/ko00780
  meta_15     Glycerol                 91.042    107.553   1.05↑      ko00040/ko02010/ko01100/ko00561/ko00052
  meta_84     L‐Ribulose               131.037   372.505   1.02↑      ko00040/ko01100
  meta_312    L‐Ascorbic acid          197.006   45.633    1.05↓      ko01120/ko01100/ko01110/ko00053/ko00480/ko02060
  meta_81     L‐Leucine                130.090   180.456   1.08↓      ko01110/ko01230/ko00280/ko02010/ko01100/ko00970/ko00290/ko01210/
  meta_1      Dihydroxyacetone         71.016    198.357   1.21↓      ko00561/ko01200/ko01100/ko01120/ko00680
  meta_533    D‐Glucose 6‐phosphate    241.007   91.875    1.24↓      ko00500/ko02060/ko05111/ko01130/ko02020/ko00521/ko00524/ko00562/ko01100
  meta_74     Citraconic acid          129.022   73.135    1.29↓      ko00630/ko00660/ko01210/ko01200/ko01100/ko00290
  meta_4      Glycolate                75.010    262.283   1.33↓      ko00361/ko00625/ko00630/ko01130/ko01110/ko01120/ko01200/ko01100
  meta_348    N‐Acetyl‐D‐glucosamine   202.076   65.036    1.42↓      ko02010/ko02060/ko00520/ko01100
  meta_293    Citrate                  191.022   376.386   2.50↓      ko00020/ko00630/ko01230/ko00250/ko01130/ko01210/ko02020/ko00720/ko01200/ko01100/ko01120
  meta_376    D‐Ribose                 209.070   204.675   2.61↓      ko00030/ko02030/ko02010
  meta_8      Pyruvate                 87.011    54.515    2.74↓      ko01220/ko01110/ko00260/ko01130/ko00010/ko00770/ko00620/ko01100/ko01200/ko00730/ko01502/ko00622/ko00660/ko00270/ko00760/ko00710/ko00250/ko00020/ko00440/ko00040/ko01210/ko00430/ko00030)/ko01230/ko00900/ko00680/ko00650/ko00630/ko01120/ko00362/ko00360/ko00621/ko00290/ko00350/ko00053/ko00473/ko02060/ko00330/ko00261/ko00720
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4. DISCUSSION {#fsn31194-sec-0019}
=============

4.1. *B. adolescentis* responses to xylose and XOS {#fsn31194-sec-0020}
--------------------------------------------------

To investigate the growth performance of *B. adolescentis* on xylose and XOS as carbon sources, growth curves of strain were determined. *Bifidobacterium adolescentis* showed a strong capacity in utilizing of XOS to proliferate, which may indicate that most genes and metabolites in *B. adolescentis* are related to XOS transport and metabolism. XOS needs to be degraded into xylose before it can be metabolized (Broekaert et al., [2011](#fsn31194-bib-0004){ref-type="ref"}). Therefore, degradation of XOS is complicated, resulting in a relatively longer lag phase when used as a substrate compared with xylose.

4.2. Gene prosperities of *B. adolescentis* ATCC 15703 {#fsn31194-sec-0021}
------------------------------------------------------

*Bifidobacterium adolescentis* ATCC 15703, the predominant species of *Bifidobacterium*, was isolated from the human GIT (Pokusaeva et al., [2011](#fsn31194-bib-0025){ref-type="ref"}). Currently, more than 40 bifidobacterial genomes including those of *B. adolescentis* 15703 strain have been completely sequenced and annotated in the NCBI database (Sayers et al., [2019](#fsn31194-bib-0026){ref-type="ref"}; Schell et al., [2002](#fsn31194-bib-0027){ref-type="ref"}). The complete genome size of the current *B. adolescentis* ATCC 15703 is 2,089,645 bp, with gene number 1701, protein 1631, and G‐C content of 59% (Bondue & Delcenserie, [2015](#fsn31194-bib-0003){ref-type="ref"}).

A recent study performed on the genome sequences from 47 *Bifidobacterium* species found that 5.5% of the core bifidobacterial genomic coding sequences were associated with carbohydrate metabolism (Milani et al., [2015](#fsn31194-bib-0023){ref-type="ref"}). The bifidobacterial genome encode a variety of carbohydrate‐modifying enzymes, such as glycosyl hydrolases, sugar ABC transporters, and PEP‐PTS system components, all of which are required for the metabolism of carbohydrates (Chen et al., [2019](#fsn31194-bib-0006){ref-type="ref"}; Liu et al., [2014](#fsn31194-bib-0018){ref-type="ref"}). Majority of these genes are devoted to carbohydrate uptake, by means of ABC transporters and permeases (Table [3](#fsn31194-tbl-0003){ref-type="table"}). According to the KEGG and COG classifications, most of genes in *B. adolescentis* 15703 are associated with carbohydrate metabolism and could imply relative importance of carbohydrate utilization.

4.3. Comparison of transport pathways of *B. adolescentis* grown on xylose and XOS {#fsn31194-sec-0022}
----------------------------------------------------------------------------------

Bifidobacteria internalize carbohydrates by ATP‐dependent ABC transporters and PEP‐PTS systems (Degnan & Macfarlane, [1993](#fsn31194-bib-0008){ref-type="ref"}; Turroni et al., [2012](#fsn31194-bib-0029){ref-type="ref"}). However, a minority of sugars utilized by bifidobacteria are believed to be internalized via a PEP‐PTS (Degnan & Macfarlane, [1993](#fsn31194-bib-0008){ref-type="ref"}; Maze, O\'Connell‐Motherway, Fitzgerald, Deutscher, & Sinderen, [2007](#fsn31194-bib-0022){ref-type="ref"}). Compared with xylose treatment, PTS beta‐glucoside transporter subunit EIIBCA (encoded by BAD_RS01940) and phosphoenolpyruvate‐protein phosphotransferase (encoded by BAD_RS00875) were downregulated in *B. adolescentis* 15703 grown on XOS. Meanwhile, metabolites including upregulated D‐Sorbitol 6‐phosphate (meta_761), D‐mannose (meta_166) and downregulated L‐ascorbic acid (meta_312), D‐Glucose 6‐phosphate (meta_533), N‐acetyl‐D‐glucosamine (meta_348), pyruvate (meta_8) were involved in PTS system (Tables [4](#fsn31194-tbl-0004){ref-type="table"} and [6](#fsn31194-tbl-0006){ref-type="table"}). Related downregulated genes and metabolites are more than upregulated ones. Therefore, uptake of the most complex sugars is possibly facilitated by specific ABC transporters.

ABC transporters couple ATP hydrolysis to efficient internalization of sugars and appear to represent the primary carbohydrate transport systems for bifidobacteria. Compared to xylose treatment, genes including the sugar transporter permease protein (encoded by BAD_RS00815, BAD_RS08280, BAD_RS00810, BAD_RS08205, BAD_RS03705, BAD_RS02260, BAD_RS07410) and transporter ATP‐binding protein (encoded by BAD_RS02265, BAD_RS00495, BAD_RS04090, BAD_RS08375) were upregulated (Table [3](#fsn31194-tbl-0003){ref-type="table"}), the same situation occurs in metabolites, including L‐threonine (meta_58), cellobiose (meta_991), D‐mannose (meta_166), L‐isoleucine (meta_82), maltotriose (meta_1695), D‐biotin (meta_651), and glycerol (meta_15) involved in ABC transporters pathway (ko02010). Thus, XOS may enhance the sugar transport process by ABC transporters system.

4.4. Comparison of carbohydrate metabolism pathways of *B. adolescentis* grown on xylose and XOS {#fsn31194-sec-0023}
------------------------------------------------------------------------------------------------

After internalization, carbohydrates can then be hydrolyzed, phosphorylated, deacetylated, and/or transglycosylated by dedicated intracellular enzymes. Glycosyl hydrolases appear to be the most critical group of enzymes for bifidobacteria. β‐glucosidases (EC3.2.1.21) are pivotal enzymes for the metabolism and homeostasis of *Bifidobacterium* because they hydrolyze small and soluble saccharides (Kelly et al., [2016](#fsn31194-bib-0012){ref-type="ref"}; Maria, Margarita, IIlia, & Iskra, [2014](#fsn31194-bib-0020){ref-type="ref"}). Compared with xylose, XOS upregulated genes involved in KEGG pathway (ko00052), including beta‐galactosidase (encoded BAD_RS07400, BAD_RS08325, BAD_RS08455, BAD_RS06400, BAD_RS07395). XOS was hydrolyzed by xylosidase to produce xylose, which was furtherly characterized to 5‐P‐xylulose with the action of xylose isomerase and xylulose kinase. The beta‐xylosidase (encoded BAD_RS02270) and alpha‐amylase (encoded BAD_RS08195) involved in KEGG pathway (ko00500 and ko00052) were upregulated. The upregulated genes were associated with some metabolites, including xylulose kinase, xylosidase, xylose isomerase, xylose proton symporter, which may pertain to the efficient utilization of XOS by *B. adolescentis*.

Carbohydrates were ultimately transformed to phosphoenolpyruvate through glycolysis and pentose conversions during the fermentation by *Bifidobacterium* and furtherly involved in the TCA cycle (Louis, Hold, & Flint, [2014](#fsn31194-bib-0019){ref-type="ref"}). L‐ribulose‐5‐phosphate 4‐epimerase involved in 5‐P‐xylulose production of pentose and glucuronate interconversion pathways (ko00040) were significantly upregulated in *B. adolescentis* 15703 grown on XOS compared with that grown on xylose. However, critical DEGs related to pyruvate metabolism and the TCA cycle (ko00620; ko00020) was only aconitate hydratase (encoded by BAD_RS05595), metabolites isocitrate (meta_211) was also upregulated in *B. adolescentis* 15703 grown on XOS. Meanwhile, phosphoenolpyruvate‐protein phosphotransferase (BAD_RS00875), Citrate (meta_293) and Pyruvate (meta_8) were significantly downregulated in *B. adolescentis* 15703 grown on XOS. A lower expression of pyruvate carboxylase may lead to the reduction in oxaloacetate, which could be fermented to produce propanoic acid through the succinate pathway and is beneficial to generate lactate (Mathew, Aronsson, Karlsson, & Adlercreutz, [2018](#fsn31194-bib-0021){ref-type="ref"}). These results indicated that XOS was preferable to be proliferated by *B. adolescentis* than xylose.

5. CONCLUSION {#fsn31194-sec-0024}
=============

To gain insights into the regulatory networks related to XOS metabolism *B. adolescentis*, a combination of transcriptome and metabolome analyses was applied to understand the utilization and metabolism of XOS in *B. adolescentis* 15703 as well as identifying the key regulatory‐related genes and metabolites. Compared with xylose, XOS highly promoted the growth of *B. adolescentis* 15703 and the fermentation performance. XOS could enhance genes involved in transport and metabolism of carbohydrate compared with xylose. Also, the metabolomic analyses, particularly those related to metabolic biomarkers of fatty acids, amino acids, and sugars showed a similar trend of results and approved the advantages of XOS as a growth medium for *B. adolescentis* 15703 compared with xylose. Abundance of specific genes and metabolites highlighted the complex regulatory mechanisms involved in *B. adolescentis* 15703 in the presence of the XOS.
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